Cargando…

Immune Response to COVID-19 mRNA Vaccine—A Pilot Study

Twenty individuals (17 females, 3 males, aged 31–65 years (range), median: 46) who received both doses of the BioNTech Pfizer mRNA vaccine were examined (11 to 31 days, median: 25) after the second dose for the presence of antibodies against peptides of SARS-COV-2 and some of MERS-CoV, SARS-CoV1, HC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lange, Andrzej, Borowik, Agata, Bocheńska, Jolanta, Rossowska, Joanna, Jaskuła, Emilia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150284/ https://www.ncbi.nlm.nih.gov/pubmed/34064613 http://dx.doi.org/10.3390/vaccines9050488

Ejemplares similares

CMV Serostatus of Donor-Recipient Pairs Influences the Risk of CMV Infection/Reactivation in HSCT Patients
por: Jaskula, Emilia, et al.
Publicado: (2012)

Intra-bone donor lymphocyte infusion at relapse: clinical outcome is associated with presence of CD8+ cells in the marrow
por: Lange, Andrzej, et al.
Publicado: (2019)

Humoral immune response to COVID-19 mRNA vaccination in relation to selenium status
por: Demircan, Kamil, et al.
Publicado: (2022)

Cytokine Overproduction and Immune System Dysregulation in alloHSCT and COVID-19 Patients
por: Lange, Andrzej, et al.
Publicado: (2021)

Anti-CMV-IgG Positivity of Donors Is Beneficial for alloHSCT Recipients with Respect to the Better Short-Term Immunological Recovery and High Level of CD4+CD25high Lymphocytes
por: Jaskula, Emilia, et al.
Publicado: (2015)

Ex Vivo Immune Responsiveness to SARS-CoV-2 Omicron BA.5.1 Following Vaccination with Unmodified mRNA-Vaccine
por: Kuechler, Anna Sabrina, et al.
Publicado: (2023)

Response to mRNA COVID-19 vaccination in three XLA patients
por: Squire, J.D., et al.
Publicado: (2022)

Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients
por: Advani, Pooja, et al.
Publicado: (2021)

RNA and mRNA Nitration as a Novel Metabolic Link in Potato Immune Response to Phytophthora infestans
por: Izbiańska, Karolina, et al.
Publicado: (2018)

Brief review of the mRNA vaccines COVID-19
por: Vitiello, Antonio, et al.
Publicado: (2021)

Myocarditis following COVID-19 mRNA vaccination
por: Abu Mouch, Saif, et al.
Publicado: (2021)

Evolution and Progress of mRNA Vaccines in the Treatment of Melanoma: Future Prospects
por: Bafaloukos, Dimitrios, et al.
Publicado: (2023)

Innate immune mechanisms of mRNA vaccines
por: Verbeke, Rein, et al.
Publicado: (2022)

Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans
por: Cagigi, Alberto, et al.
Publicado: (2021)

An mRNA vaccine elicits STING-dependent antitumor immune responses
por: Chen, Zhe, et al.
Publicado: (2023)

Analyzing immune responses to varied mRNA and protein vaccine sequences
por: Park, Hyeong-Jun, et al.
Publicado: (2023)

Immunogenicity against the Omicron Variant after mRNA-Based COVID-19 Booster Vaccination in Medical Students Who Received Two Primary Doses of the mRNA-1273 Vaccine
por: Chung, Hyemin, et al.
Publicado: (2022)

Maintenance of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients after 1273-mRNA SARS-CoV-2 Vaccination
por: Gonzalez-Perez, Maria, et al.
Publicado: (2023)

BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunity
por: Vizcarra, Pilar, et al.
Publicado: (2021)

Hypereosinophilia after vaccination with the SARS-CoV-2 mRNA vaccines
por: Westreich, Aaron, et al.
Publicado: (2023)

Evaluation of the immune response to COVID-19 vaccine mRNA BNT162b2 and correlation with previous COVID-19 infection
por: Bongiovanni, Marco, et al.
Publicado: (2021)

Humoral immune response to Comirnaty (BNT162b2) SARS-Cov2 mRNA vaccine in Thalassemia Major patients
por: Anastasi, Emanuela, et al.
Publicado: (2022)

Immune response enhancement with GLS-5310 DNA primary vaccine against SARS-CoV-2 followed by administration of an mRNA vaccine heterologous boost
por: Kim, Woo Joo, et al.
Publicado: (2023)

PEGylation of mRNA by Hybridization of Complementary PEG-RNA Oligonucleotides Stabilizes mRNA without Using Cationic Materials
por: Yoshinaga, Naoto, et al.
Publicado: (2021)

Pre-existing T cell immunity determines the frequency and magnitude of cellular immune response to two doses of mRNA vaccine against SARS-CoV-2
por: Casado, José L., et al.
Publicado: (2022)

Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines
por: Narasimhan, Madhusudhanan, et al.
Publicado: (2021)

Humoral and T-Cell Mediated Response after the Third Dose of mRNA Vaccines in Patients with Systemic Lupus Erythematosus on Belimumab
por: Quartuccio, Luca, et al.
Publicado: (2023)

Blood Antibody Titers and Adverse Reactions after BNT162b2 mRNA Vaccination
por: Kiewisz, Jolanta, et al.
Publicado: (2022)

Influenza Viruses: Innate Immunity and mRNA Vaccines
por: Lee, SangJoon, et al.
Publicado: (2021)

Durability of immune responses to mRNA booster vaccination against COVID-19
por: Arunachalam, Prabhu S., et al.
Publicado: (2023)

Allergic symptoms after mRNA COVID-19 vaccination and risk of incomplete vaccination
por: Robinson, Lacey B., et al.
Publicado: (2021)

Safety of COVID-19 mRNA vaccination in children with chronic urticaria
por: Zhu, Catherine K., et al.
Publicado: (2023)

mRNA as a Therapeutics: Understanding mRNA Vaccines
por: Oğuz, Ferdi, et al.
Publicado: (2022)

mRNA Vaccine Platform: mRNA Production and Delivery
por: Litvinova, V. R., et al.
Publicado: (2023)

Serological response to a single dose of a SARS-CoV-2 mRNA vaccine
por: Ramos, Angélica, et al.
Publicado: (2021)

Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept
por: Chavarot, Nathalie, et al.
Publicado: (2021)

SARS-CoV-2 mRNA vaccination and subsequent herpes zoster: Possible immune reconstitution by mRNA vaccination
por: Ota, Mitsuhito
Publicado: (2022)

Reducing cell intrinsic immunity to mRNA vaccine alters adaptive immune responses in mice
por: Wang, Ziyin, et al.
Publicado: (2023)

A Peptide-Based Assay Discriminates Individual Antibody Response to the COVID-19 Pfizer/BioNTech mRNA Vaccine
por: Polvere, Immacolata, et al.
Publicado: (2021)

Smoking habits predict adverse effects after mRNA COVID-19 vaccine: Empirical evidence from a pilot study
por: Ponticelli, D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dis250obprchu36ir8epbl8foj